![El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca](https://imagenesnetytec.blob.core.windows.net/simg/imgd/344000/fichero_853625_20190228.jpg)
El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca
![El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca](https://salamancartvaldia.es/e-img//351000/fichero_853612_20190228.jpg)
El doctor Cándido Martín Luengo aborda la prevención en enfermedades cardiovasculares - SALAMANCArtv AL DÍA - Noticias de Salamanca
![La mortalidad por enfermedad cardiovascular es mayor entre las mujeres, y solo el 50% de ellas conocen este dato» | El Norte de Castilla La mortalidad por enfermedad cardiovascular es mayor entre las mujeres, y solo el 50% de ellas conocen este dato» | El Norte de Castilla](https://static3.elnortedecastilla.es/www/multimedia/201902/19/media/cortadas/medico-kBoB-U70707300808LyF-624x385@El%20Norte.jpg)
La mortalidad por enfermedad cardiovascular es mayor entre las mujeres, y solo el 50% de ellas conocen este dato» | El Norte de Castilla
![PDF) Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: Randomized trial to assess infarct size limitation | Diego Dominguez - Academia.edu PDF) Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: Randomized trial to assess infarct size limitation | Diego Dominguez - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/67626749/mini_magick20210614-8181-17su3fk.png?1623702339)
PDF) Isosorbide dinitrate sublingual therapy for inferior myocardial infarction: Randomized trial to assess infarct size limitation | Diego Dominguez - Academia.edu
![Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up - The Journal of Thoracic and Cardiovascular Surgery Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up - The Journal of Thoracic and Cardiovascular Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005340494/2022968511/gr1.jpg)
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up - The Journal of Thoracic and Cardiovascular Surgery
![Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2458-10-33/MediaObjects/12889_2009_Article_1944_Fig2_HTML.jpg)
Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study
![PDF) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction PDF) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction](https://i1.rgstatic.net/publication/9011877_Autologous_intramyocardial_injection_of_cultured_skeletal_muscle-derived_stem_cells_in_patients_with_non-acute_myocardial_infarction/links/5992ae92a6fdcc53b79b75f8/largepreview.png)
PDF) Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction
![Recurrent Coronary Thrombosis, Factor V Leiden, Primary Antiphospholipid Syndrome, and HIV | Revista Española de Cardiología Recurrent Coronary Thrombosis, Factor V Leiden, Primary Antiphospholipid Syndrome, and HIV | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13066487:255v57n10-13066487fig01.jpg?idApp=UINPBA000025)
Recurrent Coronary Thrombosis, Factor V Leiden, Primary Antiphospholipid Syndrome, and HIV | Revista Española de Cardiología
![Cándido MARTÍN-LUENGO | Catedrático | Universidad de Salamanca, Salamanca | Departamento de Medicina Cándido MARTÍN-LUENGO | Catedrático | Universidad de Salamanca, Salamanca | Departamento de Medicina](https://i1.rgstatic.net/ii/profile.image/272502991618051-1441981184077_Q512/Candido-Martin-Luengo.jpg)